Intranasal:
5-17 years: 5mg-20mg administered in one nostril as a single dose
SubQ:
6-17 years: 3-6mg single dose
Efficacy of oral dosing has not been demonstrated in patients <17 years old.
5-17 years: 5mg-20mg administered in one nostril as a single dose
6-17 years: 3-6mg single dose
Sumatriptan
Nadalol
Topiramate
Diphenhydramine
Dantrolene
Riociguat
Oxcarbazepine
Fenoldopam